Assurance Infusion recalls testosterone CYP 200mg/ml oil vials due to lack of sterility assurance. Affected lots expired by February 2020.
Lack of sterility assurance.
Assurance Infusion is recalling testosterone CYP 200mg/ml oil vials that may not be sterile. This could lead to infections if used improperly.
The vials may not be sterile, which can cause infections if injected. This is a serious risk for medical users.
People using testosterone CYP 200mg/ml oil vials from Assurance Infusion. Those with medical conditions requiring injections are most at risk.
Check for vials labeled 'TESTOSTERONE CYP 200MG/ML OIL (SESAME) INJ in 10 mL vial'. Affected lots include 08212019 (expires 02/2020) and 10232019 (expires 04/2020).
Look for the lot numbers 08212019 or 10232019 on the vial.
The vials may not be sterile, which can cause infections if used.
The official notice does not specify a remedy for this recall.
The affected lots expire by February 2020 and April 2020.
We’ve drafted a message you can send Assurance Infusion to request your refund or repair — edit it as you like.
Subject: Recall D-0771-2020 — Assurance Infusion Assurance Infusion Hello, I own a Assurance Infusion that is covered by recall D-0771-2020 from Assurance Infusion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
